These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7434740)

  • 1. [Decrease in the preventive effect of immunoglobulin against hepatitis A upon repeated administration].
    Iurkuvenas VB
    Vopr Virusol; 1980; (5):599-600. PubMed ID: 7434740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of a specific immunoglobulin against hepatitis A].
    Slepushkin AN; Gorbunov MA; Stepanchuk VA; Ikoev VN; Opanasiuk LG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):52-5. PubMed ID: 2440203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccine versus immunoglobulin for post-exposure prophylaxis.
    Srivastava A; Aggarwal R
    Natl Med J India; 2007; 20(6):302-3. PubMed ID: 18335798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoglobulin or vaccine as post-exposure prophylaxis against hepatitis A. The vaccine is sufficient for many according to the first controlled study].
    Weiland O
    Lakartidningen; 2008 May 7-13; 105(19):1371-2. PubMed ID: 18574973
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin prophylaxis of infectious hepatitis.
    Andrews DA
    N Z Med J; 1971 Apr; 73(467):199-202. PubMed ID: 4102909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with the use of immunoglobulin prophylaxis of hepatitis A in the Lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin in a pre-epidemic period].
    Iurkuvenas VB; Zak MR; Sangaĭla IV; Gurchinas SV; Tarbunas SI
    Vopr Virusol; 1982; 27(2):241-3. PubMed ID: 7090351
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis for hepatitis A.
    Mann JM; Ahtone JL
    Am Fam Physician; 1982 Mar; 25(3):129-32. PubMed ID: 6278904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune serum globulin for protection against viral hepatitis. Condensed recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1973 Jan; 12(1):5 passim. PubMed ID: 4739169
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-exposure prophylaxis for hepatitis A: immune globulin, vaccine or both?
    Allam MF
    J Prev Med Hyg; 2008 Dec; 49(4):129-30. PubMed ID: 19350959
    [No Abstract]   [Full Text] [Related]  

  • 10. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with the use of immunoglobulin prophylaxis of hepatitis A in the lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin depending on the epidemic situation].
    Iurkuvenas VB; Zak MR; Sangaĭla IV; Gurchinas SV; Tarbunas SI
    Vopr Virusol; 1982; 27(2):243-7. PubMed ID: 7090352
    [No Abstract]   [Full Text] [Related]  

  • 12. Another success for hepatitis A vaccine.
    Baker CJ
    N Engl J Med; 2007 Oct; 357(17):1757-9. PubMed ID: 17947391
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis A: matching preventive resources to needs.
    Campos-Outcalt D
    J Fam Pract; 2004 Apr; 53(4):292-5. PubMed ID: 15068774
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of hepatitis A with the hepatitis A vaccine.
    Craig AS; Schaffner W
    N Engl J Med; 2004 Jan; 350(5):476-81. PubMed ID: 14749456
    [No Abstract]   [Full Text] [Related]  

  • 15. Protecting contacts of hepatitis A: what's the difference between vaccine and human normal immunoglobulin?
    Crowcroft NS
    Epidemiol Infect; 2008 Jan; 136(1):10-3. PubMed ID: 17352837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis A in Oslo].
    Hasle G; Espinoza R
    Tidsskr Nor Laegeforen; 1995 Jan; 115(2):215-7. PubMed ID: 7855814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin prophylaxis for viral hepatitis.
    Feng CS
    J Fam Pract; 1982 Apr; 14(4):677-81. PubMed ID: 6802930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The evaluation of the late effect of the multiple administration of immunoglobulin on hepatitis A morbidity in organized collectives].
    Katkov AI; Semenenko TA; Vasil'eva VI
    Voen Med Zh; 1991 Nov; (11):35-7. PubMed ID: 1668550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health control of hepatitis A: memorandum from a WHO meeting.
    Bull World Health Organ; 1995; 73(1):15-20. PubMed ID: 7704922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.